Moxidectin: From Dewormer to Fungal Sensitizer
2026-09-09
A translational perspective on how Moxidectin moves from established parasitic worm control into mechanism-driven polyene combination research against Candida albicans.
Caco-2 Permeability of Ziprasidone Nanocrystals
2026-09-09
The reference study investigated whether nanocrystal engineering could improve the in vitro transport of ziprasidone hydrochloride monohydrate across Caco-2 cell monolayers. PVP-stabilized nanocrystals increased permeability 2.3-fold versus coarse powder without reducing measured cell viability, supporting a formulation-based strategy for overcoming dissolution-limited absorption.
BAPTA Calcium Chelator Workflow for Apoptosis
2026-09-08
BAPTA enables a practical test of whether calcium elevation is causally involved in toxicant-induced apoptosis rather than merely correlated with it. This workflow translates IP3R/Ca2+/STAT3 findings into controlled cell assays, dose planning, and troubleshooting for calcium signaling modulation.
CCK8 Workflow for Lung Cancer Cell Assays
2026-09-08
Build a reproducible cck8 workflow for measuring lung cancer cell proliferation, viability, and treatment response. This guide connects WST-8 assay design with the CCT3–PI3K/AKT–EMT findings reported in the reference study, while emphasizing controls, orthogonal validation, and practical troubleshooting.
Ziprasidone HCl: Research Workflows
2026-09-07
Ziprasidone HCl supports paired neuroscience and oncology workflows, linking receptor-pathway studies with GOT1-centered tumor metabolism assays. This guide translates the compound’s reported activity into practical cell, permeability, analytical, and troubleshooting strategies.
GCN2 Surveillance of Translation Termination
2026-09-05
A 2025 Molecular Cell study shows that compromised eRF1-dependent translation termination activates GCN2 before ribosome collisions arise. This surveillance pathway phosphorylates eIF2α, suppresses translation initiation, and limits both collision formation and stop-codon readthrough across mouse and human cell systems.
Wortmannin Workflows for PI3K Signaling in HCC
2026-09-05
Wortmannin is a practical PI3K inhibitor for testing whether PI3K/AKT activation drives ferroptosis resistance, apoptosis changes, or autophagy phenotypes. This workflow translates recent FAT4–PI3K/AKT findings into controlled cell-based experiments while addressing solubility, irreversible target engagement, and concentration-dependent kinase selectivity.
Coumestrol Workflows for ER and RA-FLS Research
2026-09-04
Coumestrol combines estrogen-receptor pharmacology with a practical model for studying ferroptosis, mitochondrial stress, and inflammatory signaling in rheumatoid arthritis fibroblast-like synoviocytes. This workflow-focused guide helps researchers separate receptor effects from concentration-dependent cytotoxicity while improving assay reproducibility.
Measuring Drug Response Beyond Cell Viability
2026-09-04
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these commonly interchangeable measures capture different combinations of proliferative arrest and cell death. This framework encourages cancer researchers to use time-resolved, orthogonal assays rather than interpreting a single viability value as a complete drug-response phenotype.
Urolithin A: From Mitochondrial Quality to Fibrosis
2026-09-03
Urolithin A offers translational researchers a mechanistically distinctive way to study mitochondrial quality control, mitophagy, inflammation, and respiratory function. This article connects those questions with evidence from hepatic stellate cell metabolism while defining what is established, what remains hypothetical, and how to build a rigorous validation strategy.
3-Deazaneplanocin (DZNep) Research Workflows
2026-09-03
Build reproducible DZNep experiments for apoptosis induction in AML cells, hepatocellular carcinoma research, and cancer stem cell targeting. This guide combines epigenetic mechanism, subtype-aware assay design, practical dosing, and troubleshooting for stronger translational datasets.
Cy3 NHS ester (non-sulfonated) Workflow Guide
2026-09-02
Cy3 NHS ester (non-sulfonated), SKU A8100, provides amine-reactive orange fluorescence for labeling soluble proteins, peptides, oligonucleotides, and DNA. It is appropriate for workflows that can tolerate a DMSO or DMF co-solvent, but not for water-only labeling or delicate samples that are destabilized by organic solvent exposure.
Engage & Evasion Improves Extracellular Vesicle Therapy
2026-09-02
Liu et al. developed a sequential “Engage & Evasion” strategy in which low-CD47 extracellular vesicles first interact with and saturate the mononuclear phagocyte system, followed by CD47-high vesicles designed to resist uptake. The approach reduced liver and spleen entrapment, increased circulating vesicle levels, and improved accumulation outside major MPS organs, providing a distribution-focused framework for ischemic disease therapy.
ddATP Workflows for Controlled DNA Termination
2026-09-01
ddATP provides sequence-aware control over DNA synthesis, enabling more than conventional Sanger sequencing: it can distinguish polymerase-dependent replication, tune PCR termination, and probe repair-associated synthesis. This guide translates the mouse-oocyte break-induced replication study into practical assay designs, controls, and troubleshooting decisions.
InstaBlue Protein Stain Solution Protocol
2026-08-31
InstaBlue Protein Stain Solution provides rapid Coomassie-based visualization of protein bands in polyacrylamide gels without fixation, washing, or destaining. It is suited to routine protein electrophoresis analysis and samples intended for mass spectrometry, but compatibility with non-polyacrylamide matrices and long-term archival staining should be validated separately.
464 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page